Clinical Trial Update: Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EB01 Cream for chronic allergic contact dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis

Drugs mentioned

• EB01 Cream

Snippet

Sponsor: Edesa Biotech Inc. | Conditions: Allergic Contact Dermatitis | Phase 2 | Status: COMPLETED